 | • レポートコード：MRC2-11QY10841 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は貧血治療薬のグローバル市場について調査・分析したレポートです。種類別（鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別貧血治療薬の競争状況、市場シェア ・世界の貧血治療薬市場：種類別市場規模 2015年-2020年（鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血） ・世界の貧血治療薬市場：種類別市場規模予測 2021年-2026年（鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血） ・世界の貧血治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の貧血治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の貧血治療薬市場分析：米国、カナダ ・ヨーロッパの貧血治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの貧血治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の貧血治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの貧血治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Acceleron Pharma、Bayer、GlaxoSmithKline、Novartis、Pieris Pharmaceuticals、AMAG Pharmaceuticals、Daiichi Sankyo、Galenica、Pharmacosmos ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia.
The iron deficiency anemia market segment accounted for the major shares of the anemia drugs market during 2017. The prevalence of iron deficiency anemia is increasing in the developing as well as developed countries. Also, around 5% women and 2% men in America are affected by the iron deficiency anemia as per the National Institutes of Health (NIH)
Market Analysis and Insights: Global Anemia Therapeutics Market
The global Anemia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anemia Therapeutics Scope and Market Size
Anemia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Acceleron Pharma
Bayer
GlaxoSmithKline
Novartis
Pieris Pharmaceuticals
AMAG Pharmaceuticals
Daiichi Sankyo
Galenica
Pharmacosmos
Market segment by Type, the product can be split into
Iron Deficiency Anemia
Sickle Cell Anemia
Pernicious Anemia
Hemolytic Anemia
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anemia Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Anemia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Iron Deficiency Anemia
1.4.3 Sickle Cell Anemia
1.4.4 Pernicious Anemia
1.4.5 Hemolytic Anemia
1.5 Market by Application
1.5.1 Global Anemia Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Anemia Therapeutics Market Perspective (2015-2026)
2.2 Global Anemia Therapeutics Growth Trends by Regions
2.2.1 Anemia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anemia Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Anemia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anemia Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Anemia Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Anemia Therapeutics Players by Market Size
3.1.1 Global Top Anemia Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Anemia Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anemia Therapeutics Market Concentration Ratio
3.2.1 Global Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anemia Therapeutics Revenue in 2019
3.3 Anemia Therapeutics Key Players Head office and Area Served
3.4 Key Players Anemia Therapeutics Product Solution and Service
3.5 Date of Enter into Anemia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anemia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Anemia Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Anemia Therapeutics Market Size by Application (2015-2020)
5.2 Global Anemia Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Anemia Therapeutics Market Size (2015-2020)
6.2 Anemia Therapeutics Key Players in North America (2019-2020)
6.3 North America Anemia Therapeutics Market Size by Type (2015-2020)
6.4 North America Anemia Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Anemia Therapeutics Market Size (2015-2020)
7.2 Anemia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Anemia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Anemia Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Anemia Therapeutics Market Size (2015-2020)
8.2 Anemia Therapeutics Key Players in China (2019-2020)
8.3 China Anemia Therapeutics Market Size by Type (2015-2020)
8.4 China Anemia Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Anemia Therapeutics Market Size (2015-2020)
9.2 Anemia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Anemia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Anemia Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Anemia Therapeutics Market Size (2015-2020)
10.2 Anemia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anemia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Anemia Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Anemia Therapeutics Market Size (2015-2020)
11.2 Anemia Therapeutics Key Players in India (2019-2020)
11.3 India Anemia Therapeutics Market Size by Type (2015-2020)
11.4 India Anemia Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Anemia Therapeutics Market Size (2015-2020)
12.2 Anemia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Anemia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Anemia Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Anemia Therapeutics Introduction
13.1.4 Sanofi Revenue in Anemia Therapeutics Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Acceleron Pharma
13.2.1 Acceleron Pharma Company Details
13.2.2 Acceleron Pharma Business Overview
13.2.3 Acceleron Pharma Anemia Therapeutics Introduction
13.2.4 Acceleron Pharma Revenue in Anemia Therapeutics Business (2015-2020)
13.2.5 Acceleron Pharma Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Anemia Therapeutics Introduction
13.3.4 Bayer Revenue in Anemia Therapeutics Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Anemia Therapeutics Introduction
13.4.4 GlaxoSmithKline Revenue in Anemia Therapeutics Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Anemia Therapeutics Introduction
13.5.4 Novartis Revenue in Anemia Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Pieris Pharmaceuticals
13.6.1 Pieris Pharmaceuticals Company Details
13.6.2 Pieris Pharmaceuticals Business Overview
13.6.3 Pieris Pharmaceuticals Anemia Therapeutics Introduction
13.6.4 Pieris Pharmaceuticals Revenue in Anemia Therapeutics Business (2015-2020)
13.6.5 Pieris Pharmaceuticals Recent Development
13.7 AMAG Pharmaceuticals
13.7.1 AMAG Pharmaceuticals Company Details
13.7.2 AMAG Pharmaceuticals Business Overview
13.7.3 AMAG Pharmaceuticals Anemia Therapeutics Introduction
13.7.4 AMAG Pharmaceuticals Revenue in Anemia Therapeutics Business (2015-2020)
13.7.5 AMAG Pharmaceuticals Recent Development
13.8 Daiichi Sankyo
13.8.1 Daiichi Sankyo Company Details
13.8.2 Daiichi Sankyo Business Overview
13.8.3 Daiichi Sankyo Anemia Therapeutics Introduction
13.8.4 Daiichi Sankyo Revenue in Anemia Therapeutics Business (2015-2020)
13.8.5 Daiichi Sankyo Recent Development
13.9 Galenica
13.9.1 Galenica Company Details
13.9.2 Galenica Business Overview
13.9.3 Galenica Anemia Therapeutics Introduction
13.9.4 Galenica Revenue in Anemia Therapeutics Business (2015-2020)
13.9.5 Galenica Recent Development
13.10 Pharmacosmos
13.10.1 Pharmacosmos Company Details
13.10.2 Pharmacosmos Business Overview
13.10.3 Pharmacosmos Anemia Therapeutics Introduction
13.10.4 Pharmacosmos Revenue in Anemia Therapeutics Business (2015-2020)
13.10.5 Pharmacosmos Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Anemia Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Anemia Therapeutics Revenue
Table 3. Ranking of Global Top Anemia Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Iron Deficiency Anemia
Table 6. Key Players of Sickle Cell Anemia
Table 7. Key Players of Pernicious Anemia
Table 8. Key Players of Hemolytic Anemia
Table 9. Global Anemia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Anemia Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Anemia Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Anemia Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Anemia Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Anemia Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Anemia Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Anemia Therapeutics Players
Table 20. Global Anemia Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Anemia Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Therapeutics as of 2019)
Table 23. Global Anemia Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Anemia Therapeutics Product Solution and Service
Table 26. Date of Enter into Anemia Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Anemia Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Anemia Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Anemia Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Anemia Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Anemia Therapeutics Market Share (2019-2020)
Table 36. North America Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Anemia Therapeutics Market Share by Type (2015-2020)
Table 38. North America Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Anemia Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Anemia Therapeutics Market Share (2019-2020)
Table 42. Europe Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Anemia Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Anemia Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Anemia Therapeutics Market Share (2019-2020)
Table 48. China Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Anemia Therapeutics Market Share by Type (2015-2020)
Table 50. China Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Anemia Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Anemia Therapeutics Market Share (2019-2020)
Table 54. Japan Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Anemia Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Anemia Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Anemia Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Anemia Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Anemia Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Anemia Therapeutics Market Share (2019-2020)
Table 66. India Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Anemia Therapeutics Market Share by Type (2015-2020)
Table 68. India Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Anemia Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Anemia Therapeutics Market Share (2019-2020)
Table 72. Central & South America Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Anemia Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Anemia Therapeutics Market Share by Application (2015-2020)
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Product
Table 79. Sanofi Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 80. Sanofi Recent Development
Table 81. Acceleron Pharma Company Details
Table 82. Acceleron Pharma Business Overview
Table 83. Acceleron Pharma Product
Table 84. Acceleron Pharma Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 85. Acceleron Pharma Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Product
Table 89. Bayer Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 90. Bayer Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Product
Table 94. GlaxoSmithKline Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 95. GlaxoSmithKline Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Product
Table 99. Novartis Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 100. Novartis Recent Development
Table 101. Pieris Pharmaceuticals Company Details
Table 102. Pieris Pharmaceuticals Business Overview
Table 103. Pieris Pharmaceuticals Product
Table 104. Pieris Pharmaceuticals Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 105. Pieris Pharmaceuticals Recent Development
Table 106. AMAG Pharmaceuticals Company Details
Table 107. AMAG Pharmaceuticals Business Overview
Table 108. AMAG Pharmaceuticals Product
Table 109. AMAG Pharmaceuticals Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 110. AMAG Pharmaceuticals Recent Development
Table 111. Daiichi Sankyo Business Overview
Table 112. Daiichi Sankyo Product
Table 113. Daiichi Sankyo Company Details
Table 114. Daiichi Sankyo Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 115. Daiichi Sankyo Recent Development
Table 116. Galenica Company Details
Table 117. Galenica Business Overview
Table 118. Galenica Product
Table 119. Galenica Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 120. Galenica Recent Development
Table 121. Pharmacosmos Company Details
Table 122. Pharmacosmos Business Overview
Table 123. Pharmacosmos Product
Table 124. Pharmacosmos Revenue in Anemia Therapeutics Business (2015-2020) (Million US$)
Table 125. Pharmacosmos Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anemia Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Iron Deficiency Anemia Features
Figure 3. Sickle Cell Anemia Features
Figure 4. Pernicious Anemia Features
Figure 5. Hemolytic Anemia Features
Figure 6. Global Anemia Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Anemia Therapeutics Report Years Considered
Figure 11. Global Anemia Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Anemia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Anemia Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Anemia Therapeutics Market Share by Players in 2019
Figure 16. Global Top Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Anemia Therapeutics Revenue in 2019
Figure 18. North America Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
鎌状赤血球貧血治療薬の世界市場（～2026年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…- ファンコニ貧血治療薬の世界市場（～2026年） Market Analysis and Insights: Global Fanconi Anemia Drug Market The global Fanconi Anemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fanconi Anemia Drug Scope and Market Size Fanconi Anemia Drug market is seg…
- 化学療法誘発性貧血（CIA）の世界市場（～2026年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- 貧血・ビタミン検査の世界市場（～2026年） Anemia is a clinical condition where the human body does not have enough Red Blood Cells (RBC) or Haemoglobin or both which are paramount important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or lo…
- 化学療法誘発性貧血治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chemotherapy Induced Anemia Drug Market The global Chemotherapy Induced Anemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chemotherapy Induced Anemia Drug Scope and Market…